Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Operating Expenses (2023 - 2025)

Historic Operating Expenses for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $52.8 million.

  • CG Oncology's Operating Expenses rose 8630.46% to $52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $182.3 million, marking a year-over-year increase of 8860.39%. This contributed to the annual value of $115.8 million for FY2024, which is 10808.4% up from last year.
  • Per CG Oncology's latest filing, its Operating Expenses stood at $52.8 million for Q3 2025, which was up 8630.46% from $48.7 million recorded in Q2 2025.
  • CG Oncology's 5-year Operating Expenses high stood at $52.8 million for Q3 2025, and its period low was $9.9 million during Q1 2023.
  • For the 3-year period, CG Oncology's Operating Expenses averaged around $28.7 million, with its median value being $26.0 million (2024).
  • As far as peak fluctuations go, CG Oncology's Operating Expenses soared by 13195.16% in 2024, and later surged by 8373.77% in 2025.
  • Quarter analysis of 3 years shows CG Oncology's Operating Expenses stood at $19.4 million in 2023, then soared by 98.93% to $38.5 million in 2024, then skyrocketed by 37.11% to $52.8 million in 2025.
  • Its Operating Expenses stands at $52.8 million for Q3 2025, versus $48.7 million for Q2 2025 and $42.3 million for Q1 2025.